Home / Posts on the theme News (Page 4)

Étiquette : News

International Workshop on Chronic Lymphocytic Leukemia

  International Workshop on Chronic Lymphocytic Leukemia September 20th – 23rd, 2019 Edinburgh International Conference Centre, Edinburgh, UK   Invectys…

Read more

8th International Conference on HLA-G

8th International Conference on HLA-G July 8th – 9th 2019 Ministère de la Santé et des Solidarités, Paris, France Invectys will be attending the 8th International…

Read more

International Cancer Immunotherapy Conference 2019

Invectys will be attending the International Cancer Immunotherapy Conference 2019 in Paris.…

Read more

Healthtech Investor Days 2019, Paris, June 24-25

  Healthtech Investor Day June 24th – 25th, 2019 The Peninsula Paris, Paris, France   Pierre Langlade-Demoyen, our CEO, will be representing Invectys…

Read more

ICVI International Symposium on Immunotherapy, 2019

  ICVI International Symposium on Immunotherapy May 24th – 25th, 2019 The Royal Society, London, UK   Invectys will be attending the Institute for…

Read more

Invectys secures €15 million equity financing

Invectys secures €15 million equity financing to advance lead program INVAC-1 into groundbreaking phase II clinical trial in CLL   Financing complements the…

Read more

4,3 Millions d’Euros de levés pour initier la Phase II

After its Phase I success, Invectys raises €4.3 million to enter Phase II with both of its anti-cancer vaccines   Paris, July 12th, 2017 – This round brings…

Read more

Invectys presents its INVAC-1 therapeutic vaccine Phase...

Presentation of the Invectys clinical trial results on cancer patients at the most important worldwide oncology meeting taking place this year in Chicago, USA Paris,…

Read more